Dr. Florian Lüders

    

career

 

medical university education:

  1996 – 2001     Medical Faculty, Westfälische Wilhelms-University

 

academic career:

           – 2016 University Hospital Münster, Department of Cardiology and Angiology (formerly Medical Clinic C), most recently in senior physician position

  2017 – 2022 Practice owner Ambulantes Gefäßzentrum Münster GbR, Head of Angiology Section

  09/2022 – Vascular Medicine Outpatient Clinic Münster (GMA), Head

  12/2024 – Center for Outpatient Vascular and Coagulation Medicine Münster (ZAGG), Head

 

Memberships:

German Society for Angiology  (DGA)

German Society for Internal Medicine  (DGIM)

Physicians Committee for Responsible Medicine  (PCRM)

International Society of Physical and Rehabilitation Medicine  (ISPRM)

 

Other:
           Emergency doctor 2006 – 2017
           Intensive care doctor 2007 – 2017 ( Honorary doctor )
           Lecturer in the health sector and for health professions (health and nursing) until 2016 ( Honorary lecturer )
           Teaching assignment at the Westphalian Wilhelms University for the subject of lymphology since 2016
           Advanced training in lymphology for doctors at the Medical Association of Westphalia-Lippe (ÄKWL) since 2016

 

 

focus
Specialist in Angiology (Vascular Medicine)

specialist in internal medicine (internist)

Lymphology, emergency medicine, nutritional medicine,

physical medicine

good clinical practice (GCP)

 

Medical care priorities:

Diagnosis and Therapy of Lymphatic Diseases

Acute care of venous complications (phlebothrombosis, thrombophlebitis)
Diagnosis Therapy of phlebological (venous) diseases

Prevention of arteriosclerotic diseases (peripheral and visceral type PAOD and CAOD)
Initial acute care of peripheral arterial complications
Prevention of arterial vasculitis

Microcirculation disorders:
cutaneous / acral ischemia syndromes:
  wounds ulcerations
  Raynaud phenomenon, acrocyanosis, erythromelalgia
  livedo reticularis / racemosa / dermatitis / – vasculopathy
unclear chronic inflammatory syndrome (CIS):
  sclerosing (fibrosing) diseases
  interstitial inflammatory diseases
prevention of sclerosing (fibrosing) diseases of the microcirculation

Nutrition (nutrition)
exercise (training stimulus and regeneration)

 
 
Scientific focus:

  human physiological and pathological macro- and micro- thermo-fluid dynamics (TFD)
  vascular / perfusion imaging:
    – near-infrared spectroscopy (“hyperspectral spectroradiometry”) 500 – 1000 nm
    – infrared spectroscopy 8000 -14000 nm
    – [ 99m Tc]technetium rhenium sulfide colloid lymph scintigraphy
  physiological principles of medical care concepts

 
 

publications

Lüders F. scalability, value systems, and the role of artificial intelligence – or why a sensitive and prognostically resilient social supply structures must primarily be oriented around the individual as a “reason for existence” · December 2024 DOI: 10.13140/RG.2.2. 36769.93283 Pub Lecture

Lüders F. prevention as the only scalable option – beyond the economic tipping point in Germany's healthcare system · December 2024 DOI: 10.13140/RG.2.2.20425.25448 Pub lecture

Lüders F. Statement: Supply structures hinder service quality · Rechtsdepeche RDG · 2020,17(4)-Jul/Aug:221 Pub

Lüders F, Intramyocellular lipids Part I: Endurance: intramuscular fat accumulation and high-fat diet – how does this fit together? · Microcirculation and Lymphology- sports medicine · 1 No 1 (2020) Pub

Lüders F, Lymph and functional integrity – prologue · Microcirculation and Lymphology · 1 No 1 (2019) DOI 10.2511/mcly.v1i1.3 Pub

Lüders F, Kaier K, Kaleschke G, Gebauer K, Meyborg M, Malyar NM, Freisinger E, Baumgartner E, Reinecke H, Reinöhl J, Association of chronic kidney disease with outcomes among patients undergoing transcatheter aortic valve implantation, accepted 02/2017 · Clinical Journal of the American Society of Nephrology [CJASN] · 4.7 Impact Factor Pub

Skonetzki S *, Lüders F *, Engelbertz Ch, Malyar N, Freisinger E, Meyborg M, Reinecke H, Aging and outcome in patients with peripheral artery disease and critical limb ischemia · Journal of the American Medical Directors Association [JAMDA] · 06/ 2016 · 6,616 Impact Factor Pub
* The first two authors contributed equally to this work.

Lüders F, Fürstenberg T, Engelbertz Ch, Gebauer K, Meyborg M, Malyar N, Reinecke H, The Impact of Chronic Kidney Disease on Hospitalized Patients With Peripheral Arterial Disease and Critical Limb Ischemia · Angiology · 04/2016, DOI: 10.1177/0003319716638797 · 2,931 Impact Factor Pub

Lüders F, Engelbertz Ch, Meyborg M, Freisinger E, Malyar N, Zeller T, Reinecke H, Acute and chronic anemia and short- and long-term outcome of patients with peripheral arterial disease and critical limb ischemia · European Journal of Internal Medicine [ EJIM] · 03/2016, DOI:10.1016/j.ejim.2016.03.002 · 2,591 Impact Factor Pub

Lüders F, Bunzemeier H, Engelbertz Ch, Malyar N, Meyborg M, Roeder H, Berger K, Reinecke H, CKD and Acute and Long-Term Outcome of Patients with Peripheral Artery Disease and Critical Limb Ischemia · Clinical Journal of the American Society of Nephrology [CJASN] · 12/2015, DOI:10.2215/CJN.05600515 · 5.061 Impact Factor Pub

Lüders F, Malyar N, Meyborg M, Reinecke H, The preinterventional cystatin-creatinine ratio: a prognostic marker for contrast medium-induced acute kidney injury and long-term all-cause mortality · Nephron · 08/2015; DOI:10.1159/000438755 · 13.26 Impact Factor Pub

Lüders F, Reinecke H, Vascular diseases and complications in the context of cardiac surgery · Journal of Cardiothoracic and Vascular Surgery · 06/2015; 6(29):29. DOI:10.1007/s00398-015-0006-9 Pub

Lüders F, Doku A, Malyar NM, Reinecke H. Endovascular Management of a Periinterventional Crural Pseudoaneurysm – A Case Report and Review of Literature · International Journal of Case Reports in Medicine · DOI: 10.5171/2014.232740. Pub

Lüders F, Malyar NM, Reinecke H. Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography · Advances in Nephrology [AIN] · 09/2014; 2014. DOI:10.1155/2014/510209 Pub

Lüders F, Doku A, Malyar N, Reinecke H (2014) Endovascular Recanalization and Angioplasty of a Lengthy, 25 Years Old Superficial Femoral Artery Occlusion · J Cardiovasc Med Cardiol · 1(1): 023-025. Pub

Lüders F, Malyar N, Meyborg M, Gebauer K, Brand E, Reinecke H. Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury · Nephron Clinical Practice · 03/2013; 122(1-2):38-43. DOI:10.1159/000346105 · 1.652 Impact Factor Pub

Lüders F, Fischbach R , Seifarth H, Weßling J , Heindel W , Juergens KU. Dual-Source Computed Tomography: Effect on Regional and Global Left Ventricular Function Assessment Compared to Magnetic Resonance Imaging · RöFo – Fortschritt auf dem Bereich der R · 07/2009; 181(10):962-9. DOI:10.1055/s-0028-1109428 · 2.025 Impact Factor Pub

Lüders F. Chronic kidney disease and atrial fibrillation: data from the German Competence Network Atrial Fibrillation · NephroNews · edition 6/15, 2015 Pub

Lüders F. Claudication – an underestimated public health problem · Heartjournal · Heartcentre Münster eV Pub

 
Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lüders F, Gebauer K, Roeder N, Berger K, Malyar NM. Peripheral arterial disease and critical limb ischemia: still poor outcomes and lack of guideline adherence., European Heart Journal 02/2015; 36(15). DOI:10.1093/eurheartj/ehv006 · 15.20 Impact Factor Pub

Malyar N, Kaier K, Freisinger E, Lüders F, Kaleschke G, Baumgartner H, Frankenstein L, Reinecke H, Reinöhl J. Prevalence and Impact of Critical Limb Ischemia on In-Hospital Outcome in Transcatheter Aortic Valve Implantation in Germany. EuroIntervention. 2017 Dec 20;13(11):1281-1287· 5.165 Impact Factor Pub

Malyar N, Fürstenberg T, Wellmann J, Meyborg M, Lüders F, Gebauer K, Bunzemeier H, Roeder N, Reinecke H. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. European Heart Journal 07/2013; 34(34). DOI:10.1093/eurheartj/eht288 · 15.20 Impact Factor Pub

Malyar NM, Freisinger E, Meyborg M, Lüders F, Gebauer K, Reinecke H, Lawall H. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diabetes Complications. 2016 Apr 4. pii: S1056-8727(16)30089-7. doi: 10.1016/j.jdiacomp.2016.03.033 · 3.01 Impact Factor Pub

Malyar NM, Freisinger E, Meyborg M, Lüders F, Fürstenberg T, Kröger K, Torsello G, Reinecke H. Low Rates of Revascularization and High In-Hospital Mortality in Patients With Ischemic Lower Limb Amputation: Morbidity and Mortality of Ischemic Amputation. Angiology. 2016 Jan 13. pii: 0003319715626849· 2.97 Impact Factor Pub

Stalling P, Engelbertz C, Lüders F, Meyborg M, Gebauer K, Waltenberger J, Reinecke H, Freisinger E, Unmet medical needs in Intermittent Claudicantion with Diabetes and Coronary Artery Disease – a 'real-world' analysis on 21,197 PAD patients, Clin Cardiol. 2019 Jun;42(6):629-636. doi: 10.1002/clc.23186. Epub 2019 May 6. Pub

Richter L, Freisinger E, Lüders F, Gebauer K, Meyborg M, Malyar NM. Impact of diabetes type on treatment and outcome of patients with peripheral artery disease. Diab Vasc Dis Res. 2018 Sep 24 doi: 10.1177/1479164118793986 Pub

Meyborg M, Abdi-Tabari Z, Hoffmeier A, Engelbertz C, Lüders F, Freisinger E, Malyar NM, Martens S, Reinecke H. Outcome of patients with reduced ankle brachial index undergoing open heart surgery with cardiopulmonary bypass. Journal of Cardiothoracic Surgery 10/2015; DOI:10.1093/ejcts/ezv376 Pub

Meyborg M, Engelbertz C, Lüders F, Gebauer K, Malyar NM, Reinecke H. Acute and mid-term outcomes after treatment of multiple, recurrent restenoses of the lower limb. International angiology: a journal of the International Union of Angiology 07/2014; 34(3). · 0.83 Impact Factor Pub

Gebauer K, Engelbertz CM, Malyar N, Meyborg M, Lüders F, Freisinger E, Reinecke H. Long-Term Mortality After Invasive Angiography and Endovascular Revascularization in Patients With PAD Having Chronic Kidney Disease. Angiology. August 2015; DOI:10.1177/0003319715603184 · 2.97 Impact Factor Pub

Weber K, Gebauer K, Lüders F, Meyborg M, Malyar NM, Reinecke H. Micro-lightguide spectrophotometry (O2C®) as a predictor of intermediate outcome in patients with critical limb ischemia after percutaneous transluminal angioplasty (PTA). International angiology: a journal of the International Union of Angiology 05/2014; 33(6). · 0.83 Impact Factor Pub

Lebiedz P, Knickel L, Engelbertz C, Lüders F, Gebauer K, Berdel WE, Waltenberger J, Reinecke H. Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit. Journal of nephrology 02/2013; 27(1). DOI:10.1007/s40620-013-0016-1 · 1.45 Impact Factor Pub

alternative_text

 
 
contemplative (without institutional conflicts of interest):
Lüders F. Synthesis of Free Energy Principle and Objectification of Perceived Structures · September 2024 DOI: 10.13140/RG.2.2.10654.75846 Pub

Lüders F. conceptual differentiation of 'complexity' from 'system', 'structure' and 'motion' · October 2024 DOI: 10.13140/RG.2.2.29777.75363 Pub

Lüders F. Biophysiological Phenomenology The Product of Complex Interacting Functions within Predisposed Possibilities DOI: 10.13140/RG.2.2.14471.00162 Pub

Lüders F. Substance and Time: A Philosophical-Physical Investigation of 'Order' and the 'Ordering Process' as Constructs of Consciousness DOI: 10.13140/RG.2.2.31933.06885 Pub

Lüders F. Contemplation (religio) as an Expression of the Ability of Prediction The Functional Capacity of Contemplation and Its Coupling to Predictive Abilities through Language, Music, and Movement Patterns DOI: 10.13140/RG.2.2.20593.70244 Pub

Lüders F. The State Philosophies of Plato and Aristotle: Historical Roots, Concepts and Relevance for Modernity DOI: 10.13140/RG.2.2.35614.55368 Pub

Lüders F. Nonduality: The Art of Representing Complexity December 2024 DOI: 10.13140/RG.2.2.19184.98565 Pub

Lüders F. The Dialectic of Subjective and Objective Consciousness in Hegel's Philosophy December 2024 DOI: 10.13140/RG.2.2.14366.45124 Pub

Lüders F. Subjective and Objective Consciousness in Hegel's Philosophy – an Excourse on the Significance of Digital Media, Social Platforms, and AI for the Development of the Absolute Spirit December 2024 DOI: 10.13140/RG.2.2.26975.57762 Pub     Lecture

Lüders F. The Increase in Complexity (“Resolution”) of the Service Structure Causes an Increase in the Individual Technical Complexity (“Occupational” Specialization) of the Individual, Yet Contextually Leads to a Decrease in the Individual Physiological Complexity (“Cultural Identity” ) December 2024 DOI: 10.13140/RG.2.2.18619.73768 Pub     Pub_German     Lecture

Lüders F. The Original Unity of Physiological and Social Education -An Interdisciplinary Perspective from Anthropology, Philosophy, and Biology December 2024 DOI: 10.13140/RG.2.2.35134.80967 Pub     Pub_deutsch     Lecture

Lüders F. Tractatus and draft texts on the topics: (a) The functional integrity of the individual in highly complex, functionally dissolved societies (b) Dangers of loss of socially complex integrity and their potential consequences - A look into the history of humanity December 2024 DOI: 10.13140/RG.2.2.18383.80807 Pub_deutsch     Lecture

Lüders F. The Value Chain and Its Significance in the Complex System of Society December 2024 DOI: 10.13140/RG.2.2.14933.33767 Pub     Pub_deutsch     Lecture

Lüders F. time, identification, and prediction an interdisciplinary perspective on an ontological key concept January 2025 DOI: 10.13140/RG.2.2.31415.64165 Pub     Pub_deutsch     Lecture

 
 

reviewer for  

Stroke ( impact factor )
Perfusion ( impact factor )
Annals of Internal Medicine ( impact factor )
PLOS ONE ( impact factor )
Medicine ( impact factor )
Nephrology ( impact factor )

 

editorial board member  

Journal of Heart and Circulation
Mathews Journal of Emergency Medicine
Journal of Physical Rehabilitation Medicine

 

trial investigator  

FREERIDE ( ClinicalTrials.gov Identifier: NCT01960647 )
ALECARDIO ( ClinicalTrials.gov Identifier: NCT01042769 )
LEVANT2 Registry ( ClinicalTrials.gov Identifier: NCT01628159 )
BIOFLEX-I Europe ( ClinicalTrials.gov Identifier: NCT01661231 )
CL0017-01 (Long Lesion) ( ClinicalTrials.gov Identifier: NCT02013271 )
Carima-Study ( ClinicalTrials.gov Identifier: NCT02559622 )
Lutonix (BTK) ( ClinicalTrials.gov Identifier: NCT01870401 )
Pluristem PLX-PAD( ClinicalTrials.gov Identifier: NCT01679990 )
Initiator and establishment of the Münster Biobank pAVK registry (MPADR)

 

 

alternative_text

 

alternative_text

 

 

 

Awards:

BP award of the 16th Tri-Country Congress of the Austrian, German and Swiss Society of Angiology in 2013, Graz, Austria
“The preinterventinal cystatin-creatinine ratio: a prognostic marker for contrast medium induced acute kidney injury and long-term all-cause mortality”
pub.: Lüders F, Malyar N, Meyborg M, Reinecke H, The preinterventional cystatin-creatinine ratio: a prognostic marker for contrast medium-induced acute kidney injury and long-term all-cause mortality, Nephron. 2015;131(1):59-65 DOI:10.1159/000438755 Epub 2015 Aug 15. PMID: 26287495

 
as co-author
Three-Country Prize “Diabetic Foot” – 2016 – of the Fondation Urgo for Germany, Austria and Switzerland
Young Investigator Award – 2015 – of the German Society for Angiology
Endovascular Milestone Award (EMil) – 2015 – of the German Society for Angiology
Young Investigator Award – 2013 – of the German, Austrian and Swiss Society for Angiology

 

Abstracts:

Lüders F, Kacik M, Hyperspectral evaluation of effectiveness of decongestive therapy for lymphedema: the L-ratio, Vol 1 No 1 (2019): Microcirculation and Lymphology DOI: 10.2511/mcly.v1i1

Preinterventional cystatin C level – a highly prognostic marker? Vasa 2012; 41, Suppl.82: P2.6.

Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury. Vasa 2012; 41, Suppl.82: P4.6.

The influence of CKD on morbidity, outcomes and health care costs of patients with peripheral arterial disease in Germany from 2005 to 2009. Vasa 2013; 42, Suppl.84: PP1.2.

The preinterventinal cystatin-creatinine ratio: a prognostic marker for contrast medium induced acute kidney injury and long-term all-cause mortality. Vasa 2013; 42, Suppl.84: PP3.5.

The Impact of Chronic Kidney Disease on In-Hospital Mortality, Amputations and Costs of Patients with Peripheral Arterial Disease in Germany 2009. Vasa 2014; 43, Suppl.86: FV7.2.

Impact of acute and chronic anemia on morbidity, short- and long-term outcome of patients with peripheral arterial disease. Vasa 2014; 43, Suppl.86: P 1.07.

Impact of chronic kidney disease on acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Vasa 2014; 43, Suppl.86: P 3.01.

Impact of chronic kidney disease on outcome of patients after transcatheter aortic valve implantation – insights from nationwide German data of the years 2010-2013, DGA 2016, then VASA

Morbidity and In-hospital Outcomes of Patients with Peripheral Arterial Disease According to Fontaine Classes in Germany from 2005 to 2009. Vasa 2012; 41, Suppl.82.

Long-term follow-up of patients with recurrent in-stent stenosis of the iliac and femoral arteries. Vasa 2012; 41, Suppl.82.

Long-term mortality after percutaneous transluminal angioplasty in PAD patients with chronic kidney disease. Annual meeting of the German Society for Angiology, Graz 2013.

Recent Trends in Morbidity and In-hospital Outcomes of Inpatients with Peripheral Arterial Disease – a Nationwide Population-Based Analysis. Annual Meeting of the German Society for Angiology, Graz 2013.

Gender Related Disparity in Hospitalization and In-Hospital Outcome of Patients with Peripheral Arterial Disease. Annual Meeting of the German Society for Angiology, Graz 2013.

Outcome of patients with reduced ankle brachial index (ABI) under-going open heart surgery with cardiopulmonary bypass. Annual meeting of the German Society for Angiology, Graz 2013.

Peripheral Arterial Disease Increases In-hospital Mortality in Patients with Acute Myocardial Infarction – a Nationwide Population-based Analysis. Annual Meeting of the German Society for Angiology, Graz 2013

A contemporary analysis of the long-term prognosis of patients with peripheral arterial disease. VASA 2014;43 (Supplement):41-42.

Impact of Revascularization on Survival in Patients with Tissue Loss due to Critical Limb Ischemia. DGA Abstract FV4.3.

The Impact of Gender on Therapy and Outcome of Peripheral Artery Disease. DGA Abstract FV4.1.

Acute and mid-term outcomes after treatment of multiple, recurrent lower limb arteries of the restenoses, Vasa 2013, Suppl

Peripheral Arterial Disease Increases In-hospital Mortality in Patients with Acute Myocardial Infarction – A Nationwide Population-based Analysis, Vasa 2013, Suppl.

Incidence of Lower Extremity Amputation due to Acute and Chronic Limb Ischemia in Germany From 2002-2008, Vasa 2014, Suppl.

Long-term mortality after invasive diagnosis and endovascular revascularization in PAD patients with chronic kidney disease, abstract 80th Annual Meeting of the German Cardiac Society (Deutsche Gelsellschaft für Kardiologie “dgk”), April 2014

 
 
 
 
Research focus of the publications

Peripheral arterial disease (PAD)
A significant part of Dr. Lüders' research focuses on peripheral arterial disease. For example, a 2019 study analyzed the inadequate medical needs of patients with intermittent claudication, diabetes and coronary heart disease. The study showed that these patients often do not receive the necessary medical standard and presented a "real-world" analysis of 21,197 PAD patients. Another study examined the influence of diabetes type on the treatment and outcome of patients with peripheral artery disease, finding significant differences in treatment outcomes.

Chronic Kidney Disease and Cardiovascular Complications
Another important area of ​​research is investigating the impact of chronic kidney disease on acute and long-term health parameters. A 2013 study examined how pre-existing CKD affects acute and long-term survival of critically ill patients in intensive care units. The results showed that higher stages of CKD are associated with increased mortality rates and increased need for renal replacement therapy​ (Springer)​. Another important publication from 2015 examined long-term mortality after invasive angiography and endovascular revascularization in patients with PAD and CKD, also finding high mortality rates​.

Clinical trials and registries
Dr. Lüders has also served as principal investigator and contributor to several major clinical trials, including the FREERIDE trial, the ALECARDIO trial and the LEVANT2 registry. These trials have contributed to gaining important insights into the treatment and management of vascular disease and translating their findings into clinical practice.
 
Editorial and review activities

In addition to his research activities, Dr. Lüders also serves as a reviewer for several high-ranking journals, including Stroke, Perfusion, Annals of Internal Medicine and PLOS ONE. He is also a member of the editorial board of the Journal of Heart and Circulation and the Mathews Journal of Emergency Medicine.
 
"Through his extensive research and clinical work, Dr. Florian Lüders has made significant contributions to improving the treatment of vascular diseases. His studies have provided important insights into the risks and treatment outcomes of patients with peripheral arterial occlusive disease and chronic kidney disease, which has had a significant impact on clinical practice." (DGA)
 
   

network
Note: any of my current national or international consulting/teaching work is/are unpaid.
Physicians Committee for Responsible Medicine
German Society for Angiology/Society for Vascular Medicine eV
International Society of Physical and Rehabilitation Medicine
  Westfälische Wilhelms-University Münster
  German Institute for Vascular Health Research gGmbH (DIGG)
Clinic for Cardiology I: Coronary Heart Disease, Heart Failure and Angiology Prof. Dr. med. Holger Reinecke, Head of Section: Dr. med. Nasser Malyar
  Clinic for Vascular and Endovascular Surgery Univ.-Prof. Dr. med. Alexander Oberhuber
  Clinic for Vascular Surgery - St. Franziskus-Hospital Priv.-Doz. Dr. med. Martin Austermann
Medical Association of Westphalia-Lippe
  Practice for congenital vascular malformations Prof. Dr. Dr. med. habil. Dirk A. Loose Dr. med. Christiane Gebhardt
activities
 

Center for Outpatient Vascular and Coagulation Medicine Münster (ZAGG), management - together with Dr. med. Heinrich Richter

Vascular Medicine Outpatient Clinic Münster (GMA), management

Teaching assignment at the Westphalian Wilhelms University for the subject of lymphology since 2016

Research scholarship from the Coloplast Foundation since 2019 (hyperspectral imaging of dermal wounds and dermal replacement procedures)

Medical Association of Westphalia-Lippe (ÄKWL) - advanced training in lymphology for doctors since 2016 (fluid homeostasis and edema control, lymph, lymphatic load, lymphatic insufficiency)
- responsible ÄKWL topic complex
 

further:


expert assessor according to SGB V and SGB IX

PM Definition of the discipline "physiological medicine", DOI: 10.13140/RG.2.2.28819.35361 , Project: physiological medicine



Further training / certificates (...the most recent)
3/4/24 Regression Analyses and Special Features in Observational Studies VNR 2760512024163870072 CMS 3
3/4/24 Exercise training for peripheral arterial occlusive disease VNR 2760512023163870512 CMS 3
3/9/24 Meralgia paraesthetica: relevance, diagnosis and therapy VNR 2760512023163870348 CMS 3
3/9/24 Intraarticular conservative therapy methods for hip and knee joint osteoarthritis VNR 2760512023163870280 CMS 3
3/9/24 Perioperative arrhythmias VNR 2760512023163870272 CMS 3
3/9/24 Prehospital blood products for the care of bleeding trauma patients VNR 2760512023163870355 CMS 3
3/8/24 Extracorporeal cardiopulmonary resuscitation: evidence and implications VNR 2760512023163870389 CMS 3
3/8/24 Diagnosis and Therapy of Anorexia Nervosa in Childhood and Adolescence VNR 2760512024163870080 CMS 3
3/7/24 patients with artificial heart valves VNR 2760512023163870371 CMS 3
3/7/24 Mediation Analyses in Medical Research VNR 2760512023163870363 CMS 3
3/3/24 Diagnosis and Therapy of COPD and its Comorbidities VNR 2760512023163870215 CMS 3
3/3/24 Medial sclerosis: epidemiology and clinical significance VNR 2760512023163870181 CMS 3
3/3/24 Quality and Benefits of Artificial Intelligence in Patient Care VNR 2760512023163870231 CMS 3
3/3/24 Lipid diagnostics with special consideration of lipoprotein(a) VNR 2760512023163870298 CMS 3
3/3/24 Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid medicinal products VNR 2760512023163870488 CMS 3
2/29/24 Update: Challenge of anticoagulation in non-invasive atrial fibrillation VNR 2760709123037090017 CMS 4
2/29/24 pharmacological therapy within the framework of a holistic therapy approach VNR 2760709123091350018, CMS 4
2/29/24 Update antithrombotic therapy after revascularization VNR 2760709122055540010 CMS 4
2/28/24 Modern Immunotherapy of Psoriasis VNR 2760709123044180017 CMS 4
2/28/24 The uncomplicated urinary tract infection in women (Update) VNR 2760709123086570018 CMS 4
2/28/24 Chronic Heart Failure Interactive – Options for Reducing the Risk of Decompensation VNR 2760709123038070018 CMS 4
2/28/24 Practical Knowledge: Diabetes and Multimorbidity – Part 2 VNR 2760709123069570019 CMS 4
2/28/24 Practical Knowledge: Diabetes and Multimorbidity – Part 1 VNR 2760709123047130019 CMS 4
2/28/24 Practice-oriented update to the irritable bowel guideline VNR 2760709123047120010 CMS 4
2/28/24 Update on Interstitial Cystitis VNR 2760709124026980010 CMS 4
2/26/24 Modern Immunotherapy of Psoriasis VNR 2760709123044180017 CMS 4
2/26/24 Challenge of Anticoagulation in Practice VNR 2760709124027030013 CMS 4
2/26/24 Type 2 diabetes in the family doctor's practice - the right therapy for the VNR 27607091230941 5001 g CMS 4
2/26/24 Vitamin D deficiency in risk groups – rational determination and substitution VNR 2760709123091340019 CMS 4
2/26/24 Update: Non-alcoholic fatty liver disease VNR 2760709123062830014 CMS 4
2/26/24 treatment on prescription VNR 2760709123044250018 CMS 4
2/26/24 Tumor-associated venous thromboembolism VNR 276070912303806001 CMS 4
2/25/24 The Sense and Nonsense of Stool Analyses VNR 2760709123101670017 CMS 4
2/25/24 Interdisciplinary Therapy of Obesity VNR 2760709123054350013 CMS 4
2/25/24 Fabry disease – an interdisciplinary challenge VNR 2760709124027020014 CMS 4
2/25/24 Chronic Kidney Disease in Type 2 Diabetes – From Evidence to Practice VNR 2760709123075600016 CMS 4
2/25/24 Imaging in Multiple Sclerosis – a Case-Based Approach VNR 2760709123078190015 CMS 4
2/24/24 The uncomplicated urinary tract infection, successful therapy VNR 276070912401592001 g CMS 4
2/24/24 COPD and heart: Cardiovascular risks influenced by medication... VNR 27607091240264/001 5 CMS 4
2/24/24 Update: Successfully diagnosing diabetic neuropathy and t- VNR 276070912310017001 g CMS 4
2/23/24 Update Heart Failure  50; Options when exhausted VNR 2760709123100550012 CMS 4
2/23/24 Cannabis-based Therapy in Practice VNR 2762002024999999999 CMS 4
... ... VNR ... CMS ...
Medical Association of Westphalia-Lippe advanced training certificate  


vascularrunner
soundcloud
books
wave
contact details
   Vascular Medicine Outpatient Clinic Münster (GMA)
  •   angiology
  •   lymphology
  •   Internal Medicine
  •   Tel.: 0173 8379 851
  •   Fax: 0251 928 74075
  •   E-Mail: kontakt@gma.ms
  •   alter Steinweg 47 | 48143 Münster | Germany
  •   - Access old stone path - 2nd floor -
  •   Elevator available, barrier-free
  •   statutory insurance | private insurance
  
 
    Vascular Medicine Outpatient Clinic Münster (GMA)
    imprint
    data protection